Skip to content
10-Q

Quarterly Report

CATALENT PHARMA SOLUTIONS, INC.

0001416083-14-000007

← back to feed
Filed
Feb 10, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Feb 3, 2014 100 sh
Operating Cash Flow Q2 2014 · Dec 31, 2013 $40.4M
Operating Cash Flow Q2 2014 · Dec 31, 2012 $25.7M
Long Term Debt Q2 2014 · Dec 31, 2013 $2.67B
Long Term Debt Q2 2014 · Jun 30, 2013 $2.66B
Short Term Debt Q2 2014 · Dec 31, 2013 $59.2M
Short Term Debt Q2 2014 · Jun 30, 2013 $35M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $64.2M
Cash And Equivalents Q2 2014 · Jun 30, 2013 $106.4M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $72.8M
Cash And Equivalents Q2 2014 · Jun 30, 2012 $139M
Stockholders Equity Q2 2014 · Dec 31, 2013 −$414.1M
Stockholders Equity Q2 2014 · Jun 30, 2013 −$410.7M
Current Liabilities Q2 2014 · Dec 31, 2013 $406M
Current Liabilities Q2 2014 · Jun 30, 2013 $410.3M
Current Assets Q2 2014 · Dec 31, 2013 $612.1M
Current Assets Q2 2014 · Jun 30, 2013 $677.9M
Total Assets Q2 2014 · Dec 31, 2013 $3.07B
Total Assets Q2 2014 · Jun 30, 2013 $3.06B
Sga Expense Q2 2014 · Dec 31, 2013 $87.5M
Sga Expense Q2 2014 · Dec 31, 2013 $168.6M
Sga Expense Q2 2014 · Dec 31, 2012 $86.2M
Sga Expense Q2 2014 · Dec 31, 2012 $168M
Net Income Q2 2014 · Dec 31, 2013 −$19.2M
Net Income Q2 2014 · Dec 31, 2013 −$17.7M
Net Income Q2 2014 · Dec 31, 2012 −$27.4M
Net Income Q2 2014 · Dec 31, 2012 −$47.1M
Operating Income Q2 2014 · Dec 31, 2013 $44.5M
Operating Income Q2 2014 · Dec 31, 2013 $79.6M
Operating Income Q2 2014 · Dec 31, 2012 $45.6M
Operating Income Q2 2014 · Dec 31, 2012 $78M
Gross Profit Q2 2014 · Dec 31, 2013 $137.4M
Gross Profit Q2 2014 · Dec 31, 2013 $256.6M
Gross Profit Q2 2014 · Dec 31, 2012 $140M
Gross Profit Q2 2014 · Dec 31, 2012 $257.5M
Cost Of Revenue Q2 2014 · Dec 31, 2013 $303.3M
Cost Of Revenue Q2 2014 · Dec 31, 2013 $598.4M
Cost Of Revenue Q2 2014 · Dec 31, 2012 $296.1M
Cost Of Revenue Q2 2014 · Dec 31, 2012 $590.6M